Who owns the CYTOSCRIBE trademark?

The CYTOSCRIBE trademark is owned by BioLegend, Inc..

What class is the CYTOSCRIBE trademark registered in?

The CYTOSCRIBE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CYTOSCRIBE?

The USPTO serial number for CYTOSCRIBE is 99045524.

What is the registration number for CYTOSCRIBE?

CYTOSCRIBE is registered under USPTO registration number 8307608.

Sealvo

Home Search: CYTOSCRIBECYTOSCRIBE #99045524

Back

Updated Sep 16, 2026·28 searches this week

View on USPTO TSDR Find similar marks

CYT

USPTO Trademark Record

REGISTERED

CYTOSCRIBE

SN 99045524·Reg 8307608·Filed Feb 18, 2025

Owner BioLegend, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CYTOSCRIBE (Serial No. 99045524), Registration No. 8307608, is a registered US trademark filed on Feb 18, 2025 by BioLegend, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: June 16, 2032

Conflict Analysis

Full conflict analysis for CYTOSCRIBE (SN 99045524) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CYTOSCRIBE (Reg. #8307608) is a registered US trademark that has been protecting its owner, BioLegend, Inc., since 2025. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 18, 2025

SERIAL

99045524

REG#

8307608

REGISTERED

Jun 16, 2026

Filing Information

StatusREGISTERED

Filing DateFeb 18, 2025

Serial Number99045524

Registration No.8307608

Registration DateJun 16, 2026

Status DateJun 16, 2026

Published for OppositionSep 02, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1892856

480Jul 31, 2025

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 22, 2025

First use in commerce: Oct 22, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 16, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 27, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 27, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

May 10, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 09, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 23, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 23, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 28, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 02, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 02, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 27, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Aug 04, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Aug 04, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 04, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Aug 04, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 04, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jul 24, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 15, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 18, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Feb 18, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by BioLegend, Inc.

Additional USPTO filings from the same owner.

BIO

BIOLEGEND

76448576

BioLegend, Inc.

REGISTERED

CYT

CYTOIQ

99723950

BioLegend, Inc.

PENDING

XER

XEROSFLOW

99788804

BioLegend, Inc.

PENDING

BIO

BIOLEGEND FROM REVVITY

99562551

BioLegend, Inc.

PENDING

Other Marks by Kevin A. Oliver

Additional USPTO filings handled by the same attorney of record.

VIV

VIVOJECT

98820324

REGISTERED

VIC

VICTOR KIRA

98871344

REGISTERED

DOP

DOPLIFY

99169872

REGISTERED

LAB

LABCHIP

76461772

REGISTERED

CYTOSCRIBE

Run a conflict check

Other Marks by BioLegend, Inc.

Other Marks by Kevin A. Oliver

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company